[Federal Register Volume 72, Number 51 (Friday, March 16, 2007)]
[Notices]
[Page 12596]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E7-4865]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Institute of Standards and Technology


Notice of Prospective Grant of Exclusive Patent License

AGENCY: National Institute of Standards and Technology, Commerce.

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institute of Standards and 
Technology (``NIST''), U.S. Department of Commerce, is contemplating 
the grant of an exclusive license in the United States of America, its 
territories, possessions and commonwealths, to NIST's interest in the 
invention embodied in U.S. Patent No. 5,514,501 (Application No. 08/
255,961), titled ``Process For UV-Photopatterning of Thiolate 
Monolayers Self-Assembled On Gold, Silver and Other Substrates,'' NIST 
Docket No. 93-047US to Stratos Biosystems, LLC, having a place of 
business at 2401 Elliott Avenue, 5th Floor, Seattle, Washington 98121. 
The grant of the license would be for the field of use: Substrates for 
analysis of proteins and nucleic acids by mass spectrometry in the Life 
Sciences Research and In Vitro Diagnostic markets.

FOR FURTHER INFORMATION CONTACT: J. Terry Lynch, National Institute of 
Standards and Technology, Office of Technology Partnerships, 100 Bureau 
Drive, Stop 2200, Gaithersburg, MD 20899, Phone 301-975-2691.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty bearing and will comply with the terms and conditions of 35 
U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be 
granted unless, within thirty days from the date of this published 
Notice, NIST receives written evidence and argument which establish 
that the grant of the license would not be consistent with the 
requirements of 35 U.S.C. 209 and 37 CFR 404.7. The availability of the 
invention for licensing was published in the Federal Register on 
October 11, 1994.
    U.S. Patent No. 5,514,501 is owned by the U.S. government, as 
represented by the Secretary of Commerce. The invention is a process 
for creating a two dimensional spacial distribution pattern of ferent 
thiolate molecules on a substrate by illuminating a surface of a self-
assembled monolayer of a first thiolate compound in the presence of 
oxygen with high frequency electromagnetic radiation distributed 
according to a desired pattern, and subsequently immersing the 
illuminated substrate in a solution of a second thiolate compound so 
that molecules of the first thiolate compound in illuminated areas of 
the monolayer are exchanged for molecules of said second thiolate 
compound; and a patterned biomolecular composite formed of a substrate 
which forms a self-assembled thiolate monolayer when immersed in a 
solution of a thiolate forming compound, a thiolate monolayer deposited 
on the substrate and composed of patterned areas of first and second 
thiolate compounds, respectively, the first thiolate compound having an 
affinity for specifically or nonspecifically adsorbing a biological 
molecule, and the second thiolate compound having essentially no 
affinity for the biological molecule, and at least one biological 
material adsorbed in a corresponding pattern on the patterned areas of 
the first thiolate compound in the thiolate monolayer.

    Dated: March 9, 2007.
James E. Hill,
Acting Deputy Director.
[FR Doc. E7-4865 Filed 3-15-07; 8:45 am]
BILLING CODE 3510-13-P